• Skip to main content
  • Skip to secondary menu
  • Skip to footer

Israel News

#Israel: Israel in social media

  • About
  • Support Us
  • Tech Jobs
  • Contact

Israel Approves CytoSorb Registration, CytoSorbents Announces Gad Medical as Distributor

March 25, 2019 By admin

CytoSorbents Corporation (NASDAQ: CTSO) a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announces that the Medical Device Division of the State of Israel Ministry of Health medical device regulation unit (AMAR), has granted registration of CytoSorb in Israel, clearing the way to begin selling the device in the country.

Mr. Vincent Capponi, Chief Operating Officer of CytoSorbents stated, “We are pleased to bring CytoSorb to Israel, a country well-known for its excellent medical practices, especially in critical care and cardiac surgery, and the development and adoption of new medical technologies.”

CytoSorbents also announced its new Israeli distributor, Gad Medical, who will have exclusive rights to sell CytoSorb for all applications in Israel. Mr. David Frances, CEO of Gad Medical stated, “Now that CytoSorb is registered in Israel, we are excited to work with CytoSorbents on the launch of CytoSorb in the country. Gad Medical specializes in selling cardiovascular medical devices as the exclusive distributor for Terumo Cardiovascular in Israel, and distributes many new and innovative medical devices in other medical fields. Because of this, we believe we are ideally suited to promote and sell CytoSorb in the country.”

Israel has a population of approximately 9 million people, and has one of the largest healthcare systems in the Middle East, spending 7.6% of its gross domestic product (GDP) on healthcare each year. Its citizens are served by 44 general hospitals and the most physicians per capita in the world. All citizens are covered by universal healthcare insurance, administered by one of four national healthcare institutes, and often supplement this universal coverage with private insurance. In 2015, the Israeli Ministry of Health estimated that sepsis was the 6th leading cause of death in the country, costing approximately $1.8 billion per year to treat. According to the Israel Heart Society, heart disease is the second leading cause of death in the country. More than 10,000 cardiothoracic surgeries are performed each year at 13 medical centers.

About Gad Medical

Founded in 2013, Gad Medical is an importing and marketing company based out of Israel specializing in the health and medical fields, focusing on innovative and cutting-edge technology devices and equipment to rapidly become market leaders. The company has an annual growth rate exceeding 50% a year, marketing a variety of products in the fields of cardiovascular, Interventional cardiology and radiology, oncology, neurology and neurosurgery, orthopedics, and pain treatment.

About CytoSorbents Corporation (NASDAQ: CTSO)

CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 55 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the “cytokine storm” or “cytokine release syndrome” that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. CytoSorbents is conducting its pivotal REFRESH 2-AKI trial – a multi-center, randomized controlled, clinical trial intended to support U.S. regulatory approval of CytoSorb for use in a heart-lung machine during complex cardiac surgery to reduce organ injury. CytoSorb® has been used in more than 56,000 human treatments to date.

CytoSorbents’ purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding of nearly $26 million from DARPA, the U.S. Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM), and others. The Company has numerous products under development based upon this unique blood purification technology protected by many issued U.S. and international patents and multiple applications pending, including CytoSorb-XL™, HemoDefend™, VetResQ™, K+ontrol™, ContrastSorb, DrugSorb, and others. For more information, please visit the Company’s websites at www.cytosorbents.com and www.cytosorb.com or follow us on Facebook and Twitter.

Filed Under: Featured Posts

Footer

Recent Posts

  • October 7 and After: Atrocity and the Echo in Lisbon
  • Sailing Out, Not Standing Still: Mano Cruises and the Persistence of Movement
  • A Camera, a Festival, and the Stubborn Persistence of Stories — Haifa, October 2025
  • Bring Them Home: Two Years On
  • Evangelical Leaders Urge Trump to Reaffirm Israel’s Sovereignty over Judea and Samaria
  • Check Point and Wiz Roll Out Unified Cloud Security Solution Globally
  • Qatar in Gaza: The Fox Guarding the Henhouse
  • Ryanair Threats Fall Flat as Wizz Air Expands in Israel
  • Gustavo Petro Exposed: Colombia’s President Wages a Dangerous Campaign Against Israel
  • Microsoft vs. Israel’s Unit 8200: Trump Steps In

Media Partners

  • Cybersecurity Market
  • Media Partners
Arsen Launches Smishing Simulation to Help Companies Defend Against Mobile Phishing Threats
Databricks Launches Data Intelligence for Cybersecurity
Gartner forecasts: by 2030 preemptive cybersecurity solutions will account for half of all IT security expenditures
VirnetX Wins GSA Schedule Contract, Expands Reach Into U.S. Government Cybersecurity
CyberArk Expands Machine Identity Security with Automated Discovery and Context
A Cyberattack at Europe’s Airports: Who Could Be Behind It?
When Sharing Becomes a Liability: The Expiration of the Cybersecurity Information Sharing Act
Cyberbit Acquires RangeForce to Create AI-Powered Cyber Readiness Giant
Cloudflare’s Dual Identity: From Cybersecurity Firm to Cloud Infrastructure Powerhouse
DoiT Expands Cloud Intelligence with Acquisition of CloudWize
Studio Tel Aviv
Domain Market Research
Pxef
Technology Conference
Dossier
Press Club
Photo Contest
Israel News
Transportational
API Course

Media Partners

  • Defense Market
  • Media Partners
Epsilor Unveils Groundbreaking High Voltage Military Battery System Based on Standard NATO 6T Batteries
Sentar Awarded $32M Task Order for Defense Health Agency
Lumen Technologies has won a $223 million contract from DISA
General Dynamics Electric Boat Wins $642 Million Submarine Support Contract
AeroVironment’s JUMP 20 VTOL UAS Surpasses Expectations in Maritime Operations
Counter UAS Technology Europe 2024: Echodyne to Address Key C-UAS Conference Amidst Rapid Expansion into European Market
NATO’s July 2024 Washington, DC Summit: A Comprehensive Overview
DAF Hosts 3rd Annual Virtual Women’s Air and Space Power Symposium for Professional Development and Empowerment, March 8-10, 2023
Jacobs Wins $3.2 Billion NASA Contract for Launch Infrastructure and Ground Processing at Kennedy Space Center
Elbit Systems Ltd. has been awarded contracts $760 million for the supply of ammunition to the Israeli Ministry of Defense
Exclusive
Peppers
Defense Market
tography
3v
Prints
Opinion
Publishing House
Bootstrapping
Photography

Copyright © 2015 IsraelNews.org

Technologies, Market Analysis & Market Research Reports

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT